Opinion · 1 Dec 2025
Conference abstractPublished 3 Aug 2015
Time modeling dependent biodistribution of holmium -166-DOTA-bevecizumab in human by compartment analysis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: The main aim of this study was to develop pharmacokinetic model for the colorectal cancer complex 166Ho- DOTA-bevacizumab in normal and tumoral rat to analyze of behavior as a new composition for diagnosis and treatment. The use of compartmental analysis allows a mathematical separation of tissues and organs to determine the concentration of activity in each fraction of interest. Biodistribution studies are expensive and difficult to carry out in humans, but such data can be obtained easily in rodents and rats. Materials & Methods: We have developed a physiologically based pharmacokinetic model for scaling up activity concentration in each organ vs. time. The mathematical model uses physiological parameters including organ volumes, blood flow rates, and vascular permeabilities. The compartments (organs) are connected anatomically. This allows the use of scale-up techniques to predict new complex distribution in humans in each organ. Results: The concentration of new complex was measured in various organs at different times. The behavior of the complex ( 166Ho-DOTA-bevacizumab) was modeled as a function of time in various organs. This data was diagramed as a time function in separated graph for each organ between 2-96 hours after injection. Conclusion: The variation of integrated uptake in organs is described with summation of 8-10 exponential terms and it approximated experimental data with 1-2 % precision.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Nuclear Medicine & Radiation Therapy.
Brief report · 1 Dec 2025
AI: Precision Radionuclide Therapy Dosimetry Advancements
Brief report · 1 Dec 2025
Multi-Isotope Therapy: Powering Precision Nuclear Oncology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNuclear Medicine & Radiation Therapy
- SubjectRadiology & Imaging
- SubjectEnergy & Power
- BylineArticles whose byline prints “A R Khorami Moghaddam”
- BylineArticles whose byline prints “A Hakimi”
- BylineArticles whose byline prints “A R Jalilian”
